Results

Total Results: 449 records

Showing results for "drug".

1. Adverse Drug Events Occurring in U.S. Hospitals | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/data/infographics/adverse-drug-events.html
   August 01, 2018 - Home Data & Analytics Data Infographics Adverse Drug … Hospitals Adverse Drug Events Occurring in U.S. … Hospitals (PDF, 1.5 MB) Source:   HCUP Statistical Brief #164: Characteristics of Adverse Drug Events … reviewed August 2018 Page originally created August 2018 Internet Citation: Adverse Drug … https://www.ahrq.gov/data/infographics/adverse-drug-events.html   Back

2. CAHPS Cancer Care Survey: Drug Therapy (pdf file)
   www.monahrq.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/drug-eng-cancer-552a.pdf
   October 07, 2016 - CAHPS Cancer Care Survey: Drug Therapy CAHPS® Cancer Care Survey Version: Drug Therapy … Since it was decided that you would have drug therapy, did your drug therapy team encourage you to … Since it was decided that you would have drug therapy, did your drug therapy team tell you to call … Since it was decided that you would have drug therapy, did your drug therapy team involve your family … drug therapy?

3. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/patient-safety/reports/liability/neumiller.html
   August 01, 2017 - current study utilized the conceptual model and scheme developed by Weingart and colleagues to assess drug-drug … Top Ten Therapeutic Drug Classes Resulting in Potential Adverse Drug Events (ADEs) Therapeutic Class … Incidence and preventability of adverse drug events in nursing homes. … Incidence of adverse drug events and potential adverse drug events; implications for prevention: ADE … Drug-related morbidity and mortality. A cost-of-illness model.

4. Consumer Reports Uses AHRQ’s Evidence Reports in Drug Comparisons | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/news/newsroom/case-studies/201539.html
   January 01, 2016 - Newsroom Impact Case Studies Consumer Reports Uses AHRQ’s Evidence Reports in Drug … Newsletter Events Consumer Reports Uses AHRQ’s Evidence Reports in Drug … Mitchell said AHRQ reviews include broad reviews of a drug category, lack conflicts, and do not rely … created January 2016 Internet Citation: Consumer Reports Uses AHRQ’s Evidence Reports in Drug

5. Surge in Drug Shortages Occurred in Wake of Pandemic, Study Finds | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/news/newsletters/e-newsletter/908.html
   April 01, 2024 - Home News Newsletter AHRQ News Now Surge in Drug … Today's Headlines: Surge in Drug Shortages Occurred in Wake of Pandemic, Study Finds April 23 Webinar … supply chains revealed a significant spike in drug shortages during the COVID-19 pandemic. … Nearly 29 million adults had alcohol use disorder in 2022, according to the National Survey on Drug Use … reviewed April 2024 Page originally created April 2024 Internet Citation: Surge in Drug

6. CHIPRA 212 Appendix 1 (pdf file)
   www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-1.pdf
   January 24, 2024 - Accuneb Asthma Drug Albuterol Sulfate Asthma Drug Proventil Asthma Drug ProAir HFA Asthma Drug ReliOn … Ventolin HFA Asthma Drug Ventolin HFA Asthma Drug Qvar Asthma Drug Budesonide Asthma Drug Pulmicort … Respules Asthma Drug Symbicort Asthma Drug Alvesco HFA Asthma Drug Cromolyn Sodium Asthma Drug Flovent … Diskus Asthma Drug Advair Diskus Asthma Drug Dulera Asthma Drug Levalbuterol Asthma Drug Xopenex … Asthma Drug Metaproterenol Sulfate Asthma Drug Asmanex Twisthaler 30 Dose

7. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
   www.monahrq.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
   January 01, 2024 - Food and Drug Administration Adverse Event Reporting System (FAERS). … Expert Opin Drug Saf. 2017;16(7):761-767. 3. Bourgeois FT, Shannon MW, Valim C, Mandl KD. … Adverse drug events in the outpatient setting: an 11-year national analysis. … Pharmacoepidemiology and drug safety. 2010;19(9):901-910. 4. Perrillo RP, Martin P, Lok AS. … Food and Drug Administration and Federal Trade Commission.

8. Medicare Version of the Health Plan Survey | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/cahps/surveys-guidance/hp/about/Medicares-CAHPS-HP-Survey.html
   December 01, 2023 - The Medicare Survey includes versions for Medicare Advantage plans (including PPOs), Prescription Drug … Rating of Drug Plan (MA-PD and PDP). … Learn about the Medicare Advantage and Prescription Drug Plan CAHPS Survey .

9. AHRQ Awards $45 Million in Grants To Expand Access to Care for People With Long COVID | Agency for Healthcare Research and Quality
   www.monahrq.ahrq.gov/news/newsletters/e-newsletter/882.html
   September 01, 2023 - AHRQ Grantee Protects Patients From Drug-Drug Medication Errors . … AHRQ Grantee Protects Patients From Drug-Drug Medication Errors AHRQ grantee Daniel C. … Malone, Ph.D., is helping to make care safer by increasing understanding of drug-drug interactions and … Malone established a framework for collecting and disseminating information on drug-drug interactions … He also worked to optimize digital tools, such as drug-drug interaction alerts and shared decision-making

10. CHIPRA 201: Appendix (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-asthma-appendix.pdf
    January 24, 2024 -                                                                     Appendix: Asthma Measure 5 Drug … Device List NDC Code Brand Name Generic Product Name Route Category Drug ID Device FDA‐Age (Years …                                                                 Appendix: Asthma Measure 5 Drug … Device List NDC Code Brand Name Generic Product Name Route Category Drug ID Device FDA‐Age (Years … Device List NDC Code Brand Name Generic Product Name Route Category Drug ID Device FDA‐Age (Years

11. Medication Reconciliation Intervention Reduces Drug Discrepancies | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/news/newsletters/e-newsletter/862.html
    May 01, 2023 - Newsletter AHRQ News Now Medication Reconciliation Intervention Reduces Drug … AHRQ News Now Events Medication Reconciliation Intervention Reduces Drug … Today's Headlines: Medication Reconciliation Intervention Reduces Drug Discrepancies . … Medication Reconciliation Intervention Reduces Drug Discrepancies Taking a best possible medication … originally created May 2023 Internet Citation: Medication Reconciliation Intervention Reduces Drug

12. Kesselheim, Aaron | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/funding/training-grants/grants/active/kawards/Kawdsumkess.html
    October 01, 2014 - Description: The proposed research has three aims: Develop a comprehensive typology of off-label drug … different ways prescription drugs are used beyond the specific indications approved by the Food and Drug … pairs and determine predictors of non-evidence-based off-label drug uses. … interviews with whistle-blowers in pharmaceutical fraud cases regarding illegal promotion of off-label drug … The first study under Aim #2 has been completed which looked at trends in off-label drug use related

13. Blacks Experiencing Fast-Rising Rates of Overdose Deaths Involving Synthetic Opioids Other Than Methadone (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/dataspotlight-opioid.pdf
    February 20, 2020 - The measure of drug overdose deaths involving synthetic opioids other than methadone describes individuals … Whites and rates vary by gender within racial groups, Blacks are experiencing fast-rising rates of drug … Outcome: Drug overdose deaths involving synthetic opioids other than methadone per 100,000 population … ◆ Since 2013, a sharp increase in drug overdose deaths involving synthetics other than methadone … Drug overdose deaths involving fentanyl, 2011-2016. Natl Vital Stat Rep 2019;68(3).

14. AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug Errors in E.D. Patients | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/news/newsroom/case-studies/201509.html
    January 01, 2018 - Impact Case Studies AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug … Newsletter Events AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug … well as the dose, frequency, and pharmacy they use, in case staff needs to call and verify an unknown drug … Identifier: 2015-09 AHRQ Product(s): Research Topic(s): Adverse Drug … May 2015 Internet Citation: AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug

15. Policy Projects | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/professionals/clinicians-providers/resources/rice/ceproj.html
    October 01, 2014 - guidelines in order to understand the content, completeness, and quality of information submitted by drug … the investigators will collect background information to use in understanding the extent to which the drug … is a "breakthrough innovation" or a drug that is similar to others. … (To what extent do dossiers contain information on off-label drug uses? … Is there evidence that drug companies are submitting the same information to multiple plans?

16. PowerPoint Presentation (ppt file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK2_T4-Common_Suspected_Infections_Tools_to_Improve_Communication_and_Decision_Making.ppt
    May 01, 2014 - * Quality Improvement for Antibiotic Prescribing Problems with taking antibiotics Drug resistance … vomiting, diarrhea Secondary infections: C difficile, yeast Allergic reactions: rash, anaphylaxis Drug … In developing countries, multi-drug resistant tuberculosis in an ever-increasing challenge. … The price of innovation: new estimates of drug development costs.  … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.

17. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Food and Drug Administration Pregnancy Category Rating Pregnancy Category Explanation Category … are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug … investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug … reaction data from investigational or marketing experience, and the risks involved in use of the drug

18. Glossary | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/questions/resources/glossary.html
    November 01, 2020 - Antibiotic: A drug used to treat infections caused by bacteria and other microorganisms. … Food and Drug Administration (FDA). … After the patent runs out on a brand-name drug, companies can apply to the FDA to make a generic copy … of that drug. … Side Effect: An effect of a drug, chemical, or other medicine that is in addition to its intended effect

19. Event Investigation and Analysis Guide: Appendix A | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/patient-safety/settings/hospital/candor/modules/guide4/apa.html
    August 01, 2022 - When the drug was brought into the facility, it was a different concentration from what had been used … There has been a drug shortage of the concentration that we typically use, and we had no choice but to … Our computer system is not connected to the National Drug Database, so we can’t simply scan the bottle … We have to enter every drug into our database manually. … In this case, the drug was entered as the wrong concentration.

20. Comparison Tables for Making Healthcare Safer Reports | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/research/findings/making-healthcare-safer/comparison.html
    September 01, 2022 - ADEs: Harms Due to Diabetic Agents ADEs: Reducing Adverse Drug Events in Older Adults ADEs: Harms … Topics Patient Safety Practices  MHS I (2001) MHS II (2013) MHS III (2020) Computer Adverse Drug … Event Detection and Alerts Summary of Evidence (Not reviewed) (Not reviewed) Unit-Dose Drug … Summary of Evidence Update (Not reviewed) The Clinical Pharmacist's Role in Preventing Adverse Drug …   Teach-Back (Not reviewed) (Not reviewed) Summary of Evidence   ADEs: Reducing Adverse Drug